Skip to main content

Table 3 Criteria for evaluating the quality of headache prevalence studies

From: The methodology of population surveys of headache prevalence, burden and cost: Principles and recommendations from the Global Campaign against Headache

Quality factor

Score

-4

1

2

3

4

Sampled population

Not stated, or clinic population, or members of patient organization

Selected population (eg, health-plan members, work-place, college students) [increase score by 2 if this met the specific purpose of the study]

 

General population or community-based sample from defined region within a country, or school-based (for children)

General population or community-based sample from whole country

Sampling method

Not stated

No (or failed) attempt to secure representativeness

 

Random sample uncorrected for population demographics

Total defined population, or random sample corrected for population demographics

Number of respondents

Not stated

250-1,000

1,000-1,500

1,500-2,500

>2,500

Participation rate

Not stated, or <40%

50-59%

60-69%

70-79%

>80%

Access

Not stated

Self-administered (unsupervised) questionnaire

Telephone or face-to-face interview by untrained or unspecified interviewer(s)

Telephone or face-to-face interview by trained lay interviewer(s), medical students or nurses

Face-to-face interview with headache expert [reduce score by 1 if interviews restricted to screen-positive sub-sample]

Validation of diagnostic instrument

Instrument not specified or not validated

Validated, but sensitivity and/or specificity <60%

Validated, but sensitivity and/or specificity <70%

Validated only in screen-positive sub-sample, or in clinic or unspecified sample, but sensitivity and specificity ≥70%

Validated in target population or similar, and sensitivity and specificity ≥70%, or all diagnoses made in face-to-face or telephone interviews by headache expert

Diagnostic criteria, and application of “probable” diagnoses

Not stated

Stated, other than ICHD

ICHD (or reasonable modification), but uncertain or inappropriate analysis of “probable” diagnoses

 

ICHD (or reasonable modification) with clear exposition regarding “probable” diagnoses

Prevalence time frame

 

Not specified or not appropriate to the study purpose

Not specified, but terminology implies “present” or “current” or “recent” headache

Other specified period appropriate to the study purpose

Point, 1-day, 1-year or lifetime

  1. Possible range is -27 to +32.
  2. Quality thresholds: <9: unacceptable (data of no value); 9–23: acceptable when no other data are available; 24–27: good; ≥28: very good.